
Elon Musk predicts robots will outsmart human surgeons in 5 years: Is it true?
Elon Musk has sparked a debate online saying that robots could become better than even the world's best surgeons in the next five years.The Tesla and SpaceX CEO made this prediction while replying to a post on X by influencer Mario Nawfal.The post highlighted the progress of robotic surgery, including the American-Irish medical device company Medtronic's Hugo robot, which recently showed a high success rate in surgeries for prostate, kidney, and bladder problems.advertisement
The Hugo robot mentioned in Nawfal's post was tested in 137 real-life surgeries and had a 98.5% success rate, well above the expected 85%, according to a report.Musk pointed to his company, Neuralink, which uses a robot to perform extremely precise brain surgeries, procedures he said are too complex and delicate for human hands alone."Robots will surpass good human surgeons within a few years and the best human surgeons within [approximately] 5 year," Musk wrote.
He said Neuralink's robot had to be used because the work was too fast and precise for a human surgeon.CAN IT REALLY HAPPEN IN FIVE YEARS?advertisementRobotic surgery is a type of surgery where doctors use special machines with robotic arms to help perform operations. The doctor, while sitting behind a console, controls the robot using a computer.This helps make very small, careful movements, which can lead to less pain, smaller cuts, and faster healing for the patient.
A doctor carrying out a robotic surgery. ()
Dr Sankar Adusumilli, a US-based senior surgeon who has done over 2,400 robot-assisted surgeries, replied on Musk's post calling his prediction "misleading."He explained that robotic systems are still tools, not independent doctors."The robot doesn't do the surgery on its own. The surgeon is in control, using a console to guide the robot. Every move the robot makes comes from the surgeon. I cannot let Robot to make intricate decisions- since Every patient is different,' he said.He added that since no two patients are the same, it takes a human to make the right decision during complex surgeries."Even the best autopilot needs a skilled human pilot - same applies to surgery," Dr Adusumilli wrote.
According to Dr Sudhir Srivastava, founder of India's first indigenous surgical robot, SSI Mantra, while Musk's statement sparks an important conversation, the prediction requires nuance.He said that even though robotic systems are becoming indispensable tools in surgery, the statement, however, overlooks a fundamental truth that surgery is not solely about precision."It is equally about real-time decision-making, adaptability, and patient-specific judgment," Dr. Srivastava told India Today Digital."At present, and for the foreseeable future, robots remain tools that enhance the capabilities of skilled surgeons. They do not make clinical decisions or adapt to the wide anatomical and physiological variations present in every patient. Having personally performed and overseen thousands of robotic surgeries, I can attest that a surgeon's intuition, expertise, and adaptability are irreplaceable," he said.
First Indian surgical robot. (Photo: SSI Mantra)
advertisementAnother US-based doctor, who goes by the name 'mckalip' according to their bio, stated that robots cannot perform surgeries alone without human help."This is false. As a neurosurgeon, I promise you that no 'robot' surgeon can ever autonomously perform brain and spine surgery or likely any surgeries effectively, appropriately or safely. Too many variables require critical thinking," the user said.
An orthopaedic surgeon Dr Steven Denyer, in the comments section, said that while robots are the future, older technology will still exist. "Robots are here to stay. But we still use fax machines and whiteboards, and we can't see X-rays done at another hospital in the same city in real time," Denyer wrote.
Dr Francisco Cardoso from Brazil added that the Tesla CEO's prediction holds true but only in part, stating that unexpected things happen during surgery and robots won't be able to make spontaneous decisions.advertisement"...the surgeon needs to use creativity to solve problems, and that is what separates the best from the average. A robot is still far from having this mastery of something that it was not programmed to do," Cardoso wrote.
A Musk supporter chimed in and said, "Think of the lives that could be saved with mass-produced, high-quality robotic surgeons. It could reduce healthcare costs and help in places where doctors are few."Adding to this, Dr Srivastava agreed that while surgeons do bring sound judgement, robot-assisted surgeries can transform rural healthcare, especially telesurgery, where doctors cannot reach remote places.As technology keeps advancing, robotic surgery is becoming more common in hospitals. But experts say we're still far from a future where robots work on their own - without the help of skilled human hands.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Economic Times
26 minutes ago
- Economic Times
KKR-backed IVI to buy ART Fertility Clinics for $450 million
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel KKR-backed IVI RMA Global, a US-based leader in infertility treatment, is set to acquire ART Fertility Clinics for $400-450 million, according to people familiar with the matter. The acquisition marks a significant step in IVI RMA's global expansion, adding India to its presence in over 15 countries and more than 190 clinical offices across the US, Europe and Latin parties are in the final stages of documentation for a shareholders' agreement and are hoping to wrap up the transaction by June with private hospitals, the IVF industry in India too is witnessing consolidation as several private equity funds have been aggressive with acquisitions. In 2023, Swedish fund EQT Partners acquired a significant majority stake in Indira IVF, the largest provider of fertility services in India and top five globally in terms of annual IVF cycles, at a $1.1 billion ('9,000 crore) Fertility Clinics began in 2015 as IVI Middle East, an international arm of IVI RMA Global. In 2020, IVI RMA divested the business to Gulf Capital, which rebranded it as ART Fertility Clinics. Since then, the brand has rapidly grown, expanding across West Asia and clinics in Abu Dhabi, Dubai and Al Ain in the UAE as well as 11 centres across India, ART Fertility has established itself as a high-performance network in reproductive medicine. The Indian expansion began in 2021, backed by a $30 million investment from Gulf Fertility operates in big Indian cities including Mumbai, Noida, Ahmedabad, Chennai, Hyderabad, Gurgaon and by Suresh Soni, former co-founder and CEO of Nova IVF Fertility, ART Fertility reports a pregnancy success rate of 70% and has recorded over 5,000 successful pregnancies in under nine to sources, ART Fertility posted revenue of $100-120 million in FY25, with an estimated Ebitda of $35 million."For an Indian healthcare player, a $25-35 million ebitda which is borderline ebitda positive coming from the Middle East would add no value," said a fund manager at a Mumbai-based private equity firm that operates a pan-India IVF chain. "However, IVI being a US player where multiples are low, adding a Middle East business works well."IVI RMA trumped a rival bid by Temasek-backed Cloudnine Hospitals.A KKR spokesperson declined to comment. IVI RMA and ART Fertility did not respond to is the advisor in the is rapidly emerging as one of the world's fastest-growing markets for Assisted Reproductive Technology (ART). However, the sector has scope for expansion at 210 IVF cycles per million people, compared with 1,200 in the US and over 2,000 in affects approximately 15% of Indian couples, a figure expected to rise due to lifestyle factors such as poor diet, stress, late marriages, and to EY, India's IVF market is expected to grow from $793 million in 2020 to $1.45 billion by 2027, at a projected CAGR of 15-20%.India sees around 300,000 IVF cycles annually, with projections suggesting this could grow to 500,000-600,000 cycles by 2030. About 30% of the market is controlled by 10-15 organised players, while the remaining is fragmented among smaller, unorganised clinics. Key players in India's fertility sector include Indira IVF, Nova IVF, Oasis IVF, Bloom Fertility Centre, Bengaluru-based Milann, Morpheus IVF, Ridge IVF, Akanksha IVF and Bourn Hall IVF, the second largest player in India, is owned by Asia Healthcare Holdings (AHH), the single specialty hospitals platform backed by GIC and homegrown PE fund Kedaara Capital owns a minority stake in Oasis Fertility, while Brussels-based fund Verlinvest owns a controlling stake in Ferty9 F, a premier chain of fertility clinics in the AP/Telangana region.


Time of India
an hour ago
- Time of India
Seminar on MBBS, global education pathways in Pune draws enthusiastic response
1 2 P une: A large gathering of aspiring students and parents attended an informative Mission Admission seminar organised by The Times of India jointly with The Astute Academy at Dr. Kalmadi Shamarao Junior College auditorium on Sunday. Conducted by Tushar Vinod Deoras, a former BARC scientist and chairman of Astute Academy, the seminar aimed to demystify the complexities of Indian and international admissions for MBBS and higher education. The first session focused on the Indian MBBS admission process, offering clarity for students with NEET scores as low as 200. Attendees also learned about affordable pathways to study medicine in the United States through structured Indo-American university collaborations. The second session delved into undergraduate and postgraduate admissions in the US and Germany. Parents and students were provided with detailed guidance on securing spots at prestigious universities abroad. During the first session, Deoras shared a wealth of information. He pointed out that many private medical colleges offer donation-free management quota merit seats. He explained fee structures, wherein funding is controlled by govt, and proposed to students tripartite Indo-American university partnered systems, which provide affordable, sophisticated modern medical education in the US and subsequently offer employer-relevant value around the globe. The second session was about undergraduate and postgraduate courses offered in the US and Germany, particularly emphasising on Ivy League schools and Germany's technical universities. Deoras noted how flexible and multidisciplinary the US system is, with more emphasis on career focus than rigid course structures. He urged students to start building their profiles as early as Std IX and to apply to international universities at least one year in advance, as most operate on a first-come, first-served basis. He said, "Quality education and a successful career are a student's fundamental right. Students and parents should not judge countries by stereotypes but understand which system aligns best with the student's goals." A highlight of the seminar was its interactive nature. One parent shared, "The session was very enlightening. Many doubts regarding my son's education were resolved, and I feel much more at peace now." Another participant raised a query about dentistry as a career path, to which Deoras responded that it remains an underappreciated but highly rewarding field in India. While initial years in practice may be challenging, dentistry offers significant long-term growth and financial prospects. Deoras also addressed several audience questions about state-wise admission quotas for MBBS, the application process for foreign universities, and the admission timelines and requirements for medical education abroad. The seminar concluded with a positive response from the audience who appreciated the transparency, practical guidance, and motivational approach.


Deccan Herald
an hour ago
- Deccan Herald
Tesla's Optimus humanoid robot program head exiting firm
The head of Tesla's Optimus program, Milan Kovac, is leaving the company, casting uncertainty over chief executive Elon Musk's humanoid robot project, Bloomberg News reported on Friday, citing a person familiar with the vice president and head of engineering for Optimus, told colleagues on Friday that he was departing, effective immediately. Ashok Elluswamy, who leads Tesla's autopilot teams, will take on Kovac's role, the report has earlier said he expected Tesla to make thousands of Optimus robots this said in April that China's export restrictions on rare-earth magnets had affected production of the humanoid has shifted focus to launching the robots and its robotaxi service, with much of the company's valuation hanging on that bet."The only things that matter in the long term are autonomy and Optimus," Musk told CNBC in an interview in May. WHAT IS A HUMANOID ROBOT?A humanoid robot is a type of robot that is designed to resemble and behave like a human. It typically has a human-like body shape, which may include a head, two arms, a torso, and two legs. Some humanoid robots also mimic facial features and expressions, enabling them to interact more naturally with Resembles the human form (at least partially).Movement: Can walk, talk, gesture, or even dance like a Equipped with cameras, microphones, and touch sensors to perceive the intelligence: Can understand speech, recognise faces, or respond to emotions (in advanced models).